- Home
- THCH vs MRNS Comparison
THCH vs MRNS Comparison
Compare THCH & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- MRNS
- Stock Information
- Founded
- THCH 2018
- MRNS 2003
- Country
- THCH China
- MRNS United States
- Employees
- THCH N/A
- MRNS N/A
- Industry
- THCH Blank Checks
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- MRNS Health Care
- Exchange
- THCH Nasdaq
- MRNS Nasdaq
- Market Cap
- THCH 123.1M
- MRNS 104.7M
- IPO Year
- THCH N/A
- MRNS 2014
- Fundamental
- Price
- THCH $0.72
- MRNS $1.74
- Analyst Decision
- THCH
- MRNS Buy
- Analyst Count
- THCH 0
- MRNS 9
- Target Price
- THCH N/A
- MRNS $9.75
- AVG Volume (30 Days)
- THCH 109.7K
- MRNS 751.9K
- Earning Date
- THCH 11-13-2024
- MRNS 11-05-2024
- Dividend Yield
- THCH N/A
- MRNS N/A
- EPS Growth
- THCH N/A
- MRNS N/A
- EPS
- THCH N/A
- MRNS N/A
- Revenue
- THCH $210,072,270.00
- MRNS $30,263,000.00
- Revenue This Year
- THCH N/A
- MRNS $21.18
- Revenue Next Year
- THCH N/A
- MRNS $56.42
- P/E Ratio
- THCH N/A
- MRNS N/A
- Revenue Growth
- THCH 12.63
- MRNS 16.56
- 52 Week Low
- THCH $0.57
- MRNS $1.05
- 52 Week High
- THCH $2.30
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- THCH 47.53
- MRNS 54.04
- Support Level
- THCH $0.62
- MRNS $1.73
- Resistance Level
- THCH $0.78
- MRNS $1.83
- Average True Range (ATR)
- THCH 0.07
- MRNS 0.11
- MACD
- THCH -0.01
- MRNS -0.01
- Stochastic Oscillator
- THCH 42.61
- MRNS 46.15
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.